Rhythm

Medtronic (MDT) First To Receive Health Canada Licence For MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

BRAMPTON, Ontario, July 26, 2017 (GLOBE NEWSWIRE) — Medtronic Canada, a subsidiary of Medtronic plc, today announced it has received a Health Canada licence and is launching its first and only magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for heart failure. Heart failure causes or contributes to […]

AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

AliveCor Press Release July 19, 2017 – Mountain View, CA – AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced a collaboration with Mayo Clinic to develop tools for medical and non-medical personnel to easily screen for long QT syndrome (LQTS) early by combining AliveCor’s AI technology with […]

Cardiac Science (CSCX) Release: Canadian Regulatory Authority Approves Powerheart G5 Automatic AED

DEERFIELD, Wis., July 20, 2017 /PRNewswire/ — Cardiac Science, a leading global manufacturer of potentially life-saving automated external defibrillators (AEDs), announced today that it has been granted approval by the Canadian regulatory agency, Health Canada, to begin marketing its fully automatic Powerheart® G5 AED in Canada. The approval represents a milestone for Cardiac Science […]

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

LAKE OSWEGO, Ore., July 19, 2017 /PRNewswire/ — BIOTRONIK today announced FDA approval and availability of the Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillator (ICD) systems. The launch of Intica CRT-DX extends the proven benefits of BIOTRONIK’s DX technology to heart failure patients. DX eliminates the need for an atrial […]

AtriCure (ATRC) Announces Hiring Of Chief Technology Officer

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has hired Salvatore (Sam) Privitera as its Chief Technology Officer. Mr. Privitera will have responsibility for Research and Development activities, as well as Operations, including manufacturing, […]

Hope of a New Future for Patients with Heart Failure Using New Implantable Hemodynamic Monitoring Technologies, is Highlighted in New Issue of the Journal of the American College of Cardiology

TEL AVIV, Israel–(BUSINESS WIRE)–A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current and next-generation implantable hemodynamic monitors and how new approaches focused on the direct measurement of left atrial pressure (LAP), seek to expand the use of pressure-guided congestive heart failure […]

The Heart Rhythm Society (HRS) is pleased to announce the grant recipients of 2017 AFib Screening Initiative

Press Release by Heart Rhythm 2017, July 11, 2017 Media Contact           Shane Osborne Heart Rhythm Society media@hrsonline.org 202-464-3431 The 2017 Atrial Fibrillation (AFib) Screening and Education Initiative is designed to increase awareness of AFib among patients and caregivers, support the development of an AFib screening and education program, and collect […]

iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford

SAN FRANCISCO–(BUSINESS WIRE)–iBeat, a wearable technology company empowering people to live longer lives, today announced it has closed another $3 million in funding, bringing its total seed stage funding to $4.5 million. New investors include WTI, SV Tech Ventures, Lee Equity, and renowned entrepreneurs and angel investors Michael Rubin, Mark Burg, and Harald Ludwig. They join […]

Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation

Press Release DUBLIN – July 11, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI) with the Arctic Front Advance(TM) Cryoballoon in patients with symptomatic paroxysmal atrial fibrillation (AF) prior […]

Cardiac Insight’s “Cardea SOLO” Supports Top Arrhythmia Experts’ Acknowledgement: Wearable Cardiac Monitors Are Effective For Tracking Atrial Fibrillation Following Cardiac Ablation

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that its FDA-approved Cardea SOLO™ ECG monitoring system is available for diagnosing atrial fibrillation following cardiac ablation. The company’s cardiac monitoring device supports a recent formal consensus statement by experts from 11 leading […]